Similarly, Van Doorn et al (10), using RIA, found subnormal IGFBP-4 levels in subjects with primary hyperparathyroidism due to adenoma or hyperplasia, supporting what we observed in a secondary hyperparathyroid state in the present study. Here, IGFBP4 is linked to primary hyperparathyroidism.